Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,826
Closed -$1.34M 285
2024
Q2
$1.34M Sell
10,826
-133
-1% -$17.1K 0.04% 217
2024
Q1
$1.45M Buy
+10,959
New +$1.35M 0.04% 209
2023
Q1
Sell
-3,867
Closed -$429K 287
2022
Q4
$429K Sell
3,867
-204,438
-98% -$20.9M 0.01% 268
2022
Q3
$17.7M Sell
208,305
-635,149
-75% -$56.7M 0.46% 73
2022
Q2
$76.9M Sell
843,454
-210,225
-20% -$18.6M 1.84% 5
2022
Q1
$86.5M Buy
1,053,679
+342,981
+48% +$27M 1.75% 6
2021
Q4
$54.5M Sell
710,698
-29,947
-4% -$2.39M 0.99% 17
2021
Q3
$55.6M Buy
740,645
+88,088
+13% +$6.7M 1.09% 16
2021
Q2
$61.4M Buy
652,557
+111,550
+21% +$8.3M 1.16% 12
2021
Q1
$39.8M Buy
+541,007
New +$39.9M 0.8% 24

Other funds holding MRK

NFJ Investment Group's MRK Position: Q3 2024 in Review

NFJ Investment Group sold out of Merck (MRK) in Q3 2024, closing a stake of 10,826 shares — an estimated $1.34M sold.

NFJ Investment Group first reported a position in MRK in Q1 2021 and held it in 10 quarters. The position peaked at $86.5M in Q1 2022. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • NFJ Investment Group reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
  • NFJ Investment Group sold 10,826 Merck shares in Q3 2024, an estimated $1.34M.
  • NFJ Investment Group first reported a position in Merck in Q1 2021 and held it in 10 quarters.
  • NFJ Investment Group's Merck position peaked at $86.5M in Q1 2022.
  • 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on NFJ Investment Group's 13F filing for Q3 2024, filed 14 Nov 2024.